Positive

From Nasdaq: 2025-03-15 16:00:00

Validea’s guru fundamental report for INTRA-CELLULAR THERAPIES INC (ITCI) shows it rates highest using the Quantitative Momentum Investor model based on Wesley Gray’s strategy. ITCI is a large-cap value stock in the Biotechnology & Drugs industry with a rating of 72% based on underlying fundamentals. The strategy looks for stocks with strong and consistent intermediate-term relative performance. The stock meets most of the strategy’s tests, indicating some interest in the stock. Wesley Gray, an expert in quantitative investing strategies, is the founder of Alpha Architect and author of books on momentum-based stock selection and value investing.



Read more at Nasdaq: ITCI Quantitative Stock Analysis | Nasdaq